i-80 Gold Corp.
For the period ended Mar 31, 2025. Filed May 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 5, 2025
IAUX$1.42+4.4%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Changes in Equity (unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
| Share Capital | ||||||
|---|---|---|---|---|---|---|
| Issued and outstanding | Note | Number ofshares | Common shares | Additional paid-in capital | Accumulated deficit | Total equity |
| Balance as at December 31, 2023 | 298,502,334 | $489,270 | $19,311 | $(163,285) | $345,296 | |
| Issued from financing activities | 7 | 13,064,204 | 17,436 | — | — | 17,436 |
| Issuance of common shares related to contingent payments | 7 | 2,727,336 | 3,564 | — | — | 3,564 |
| Issued on exercise of stock options | 7 | 594,800 | 1,269 | (683) | — | 586 |
| Share-based compensation | — | — | 355 | — | 355 | |
| Share issue costs | — | (380) | — | — | (380) | |
| Net loss | — | — | — | (19,700) | (19,700) | |
| Balance as at March 31, 2024 | 314,888,674 | $511,159 | $18,983 | $(182,985) | $347,157 | |
| Balance as at December 31, 2024 | 409,786,956 | $606,505 | $18,977 | $(284,818) | $340,664 | |
| Issued from financing activities | 7 | 33,551,854 | 18,731 | — | — | 18,731 |
| Issued on exercise of stock options | 7 | 20,000 | 52 | (43) | — | 9 |
| Share-based compensation | 7 | — | — | 49 | — | 49 |
| Share issue costs | — | (290) | — | — | (290) | |
| Net loss | — | — | — | (41,205) | (41,205) | |
| Balance as at March 31, 2025 | 443,358,810 | $624,998 | $18,983 | $(326,023) | $317,958 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.